It was also discussed on Business Spectator this...

It was also discussed on Business Spectator this morning.

"Staying in the healthcare sector, with Sigma Pharmaceuticals new boss Mark Hooper set to deliver a pretty grim set of numbers today there is talk that a merger of the new look business ? minus the pharmacy arm ? with a industry rival could be on the cards. According to The Australian Financial Review, the latest speculation has been fuelled by the rapid rise in the share price of Sigma?s rival Australian Pharmaceutical Industries (API). API share have climbed 15 per cent this week and the paper suggests that investors may be hoping that plans of an API-Sigma merger may be revived once Sigma becomes a wholesaler. A merger between the two was scuttled by the competition regulator eight years ago."